Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Merck & Co., Inc. Director's Dealing 2021

Oct 1, 2021

284_dirs_2021-10-01_72926ba1-06e9-40af-8202-aa387471f5d0.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Merck & Co., Inc. (MRK)
CIK: 0000310158
Period of Report: 2021-09-30

Reporting Person: GLOCER THOMAS H (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-09-30 Phantom Stock $ A 116.4958 Acquired Common Stock (116.4958) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 5100 Direct

Footnotes

F1: 1-for-1

F2: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

F3: Holdings include shares acquired in dividend reinvestment transactions.